Therapeutic effect of mirtazapine with venlafaxine in the treatment of tension headaches
Phase 3
Recruiting
- Conditions
- Tension headaches.Cluster headaches and other trigeminal autonomic cephalgias (TAC)G44.0
- Registration Number
- IRCT20210410050915N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
All patients for whom the diagnosis of tension headache has been confirmed by a neurologist.
The patient has the consent to participate in the study.
Exclusion Criteria
Patients who do not have the consent to enter the study.
Patients with chronic physical diseases such as kidney-liver, heart, lung, cancer, autoimmune, etc. and mental problems.
A specialist doctor has diagnosed them with other headaches such as migraines.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce pain. Timepoint: Before the intervention, three months and six months later. Method of measurement: Comparison of therapeutic effect of mirtazapine with venlafaxine.
- Secondary Outcome Measures
Name Time Method